Immunitybio Inc (IBRX) — Quality & forensics
As of 2026-10-14 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 5
- Quality 23
- Growth 76
- Balance sheet 33
- Cash quality 52
- Capital allocation 4
- Momentum 79
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the distress zone (below 1.81). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — above the −1.78 threshold the literature flags for earnings-manipulation risk. A screen, not an accusation.
Continue: the IBRX chart & overview · the earnings record
FAQ · from the current data · as of 2026-10-14
Quick answers
What is Immunitybio Inc's Closelooknet quality reading?
The composite reads 39/100 across 7 modules, as of 2026-10-14: valuation 5, quality 23, growth 76, balance sheet 33, cash quality 52, capital allocation 4, momentum 79. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Immunitybio Inc's Altman Z-Score?
-5.06, which sits in the distress zone (below 1.81) as of 2026-10-14. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Immunitybio Inc's Piotroski F-Score?
5 of 9, as of 2026-10-14. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Immunitybio Inc's Beneish M-Score indicate?
4.27 — above the −1.78 threshold the literature flags for earnings-manipulation risk, as of 2026-10-14. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- KRYS Krystal Biotech Incindustry
- UCB.BR UCB SAindustry
- PTGX Protagonist Therapeutics Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- EXEL Exelixis Incindustry
- RXRX Recursion Pharmaceuticals Incindustry
- TWST Twist Bioscience Corpindustry
- TECH Bio-Techne Corpindustry
- RPRX Royalty Pharma Plcindustry
- ONC BeiGene, Ltd.industry
- REGN Regeneron Pharmaceuticals Incindustry
- RVMD Revolution Medicines Incindustry
- BION.SW BB Biotech AGindustry
- ROIV Roivant Sciences Ltdindustry